PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

FDA grants fast-track designation for Istesso’s IPF candidate

The therapy has reduced inflammation and supported the remodelling of damaged bone. Istesso – a London-based immunometabolism drug development company – has annou...
Continue Reading →
News

Valneva and Pfizer report Lyme disease antibody data

Children and adults have been treated using the Lyme disease antibody candidate VLA15 Pfizer has reported antibody persistence data six months after the completio...
Continue Reading →
News

Merck KGaA’s arpraziquantel validated by European Medicines Agency

Positive scientific opinion by EMA would create a pathway for arpraziquantel in African endemic countries. Merck KGaA (Merck) – known as EMD Serono in the US and ...
Continue Reading →
News

Almirall Joins Project to Allow Study Participants to Use Trial Data

The project involves 27 partners including patient associations, hospitals and universities. Almirall – a company focused on skin health – is participating in Facili...
Continue Reading →
News

C4XD Signs NRF2 Activator Deal with Astrazeneca

C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial. C4XD – a company focused on drug discovery – has signed a global licensing a...
Continue Reading →
News

Bristol Myers Squibb Immunotherapy-Chemo Combination Gets NICE Recommendation

Treatment involves adults with certain forms of advanced stomach and oesophageal cancer. Bristol Myers Squibb (BMS) has announced that the National Institute for Hea...
Continue Reading →
News

Depressive Therapy Spravato Demonstrates Superior Efficacy

Research supports the use of Spravato nasal spray in adults with major depressive disorder. The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) h...
Continue Reading →
News

Storm Doses First Patient with Solid Tumour Drug Candidate

A candidate is the first molecule targeting an RNA methyltransferase enzyme to enter development. Storm – a company focusing on the development of novel small molecu...
Continue Reading →
News

Multi-drug precision medicine cancer trial begins

Patients on the trial will have one of the particular genetic mutations among rare cancers. Cancer Research UK, The University of Manchester, and Roche have announce...
Continue Reading →
News

Takeda findings may minimise haemophilia treatment side effects

Research from Takeda and Institute Krems Bioanalytics of IMC Krems will help treat patients. Immune responses against factor VIII (FVIII) – used to treat haemophi...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026